Rossman M - Search Results

1

HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.

Crooks J, Mroz MM, VanDyke M, McGrath A, Schuler C, McCanlies EC, Virji MA, Rosenman KD, Rossman M, Rice C, Monos D, Fingerlin TE, Maier LA. Crooks J, et al. Among authors: rossman m. Occup Environ Med. 2022 Feb;79(2):120-126. doi: 10.1136/oemed-2021-107736. Epub 2021 Sep 17. Occup Environ Med. 2022. PMID: 34535537 Free PMC article.

2

Recent chronic beryllium disease in residents surrounding a beryllium facility.

Maier LA, Martyny JW, Liang J, Rossman MD. Maier LA, et al. Am J Respir Crit Care Med. 2008 May 1;177(9):1012-7. doi: 10.1164/rccm.200607-1042OC. Epub 2008 Jan 31. Am J Respir Crit Care Med. 2008. PMID: 18244954

3

HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.

Rosenman KD, Rossman M, Hertzberg V, Reilly MJ, Rice C, Kanterakis E, Monos D. Rosenman KD, et al. Among authors: rossman m. Occup Environ Med. 2011 Jul;68(7):487-93. doi: 10.1136/oem.2010.055046. Epub 2010 Dec 23. Occup Environ Med. 2011. PMID: 21186201 Review.

4

Lack of an Exposure Response and Interaction With HLA-DPβ1 and DRβ1 Polymorphisms in the Development of Beryllium Toxicity in a High Beryllium Exposure Cohort.

Widyaningsih V, Rosenman K, Reilly MJ, Wang L, Pathak DR, Gardiner JC, Rice C, Monos D, Rossman M. Widyaningsih V, et al. Among authors: rossman m. J Occup Environ Med. 2020 Jan;62(1):64-73. doi: 10.1097/JOM.0000000000001766. J Occup Environ Med. 2020. PMID: 31743304

5

Chronic beryllium disease and sensitization at a beryllium processing facility.

Rosenman K, Hertzberg V, Rice C, Reilly MJ, Aronchick J, Parker JE, Regovich J, Rossman M. Rosenman K, et al. Among authors: rossman m. Environ Health Perspect. 2005 Oct;113(10):1366-72. doi: 10.1289/ehp.7845. Environ Health Perspect. 2005. PMID: 16203248 Free PMC article.

6

Analysis of single nucleotide polymorphisms in chronic beryllium disease.

Frye BC, Gaede KI, Saltini C, Rossman MD, Monos DS, Rosenman KD, Schuler CR, Weston A, Wegner R, Noth R, Zissel G, Schreiber S, Nothnagel M, Müller-Quernheim J. Frye BC, et al. Among authors: rossman md. Respir Res. 2021 Apr 16;22(1):107. doi: 10.1186/s12931-021-01691-2. Respir Res. 2021. PMID: 33863318 Free PMC article.

7

Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.

Schuler CR, Kent MS, Deubner DC, Berakis MT, McCawley M, Henneberger PK, Rossman MD, Kreiss K. Schuler CR, et al. Among authors: rossman md. Am J Ind Med. 2005 Mar;47(3):195-205. doi: 10.1002/ajim.20140. Am J Ind Med. 2005. PMID: 15712254

8

Genetic markers in beryllium hypersensitivity.

Stubbs J, Argyris E, Lee CW, Monos D, Rossman MD. Stubbs J, et al. Among authors: rossman md. Chest. 1996 Mar;109(3 Suppl):45S. doi: 10.1378/chest.109.3_supplement.45s. Chest. 1996. PMID: 8598150 No abstract available.

9

SKDM human leukocyte antigen (HLA) tool: A comprehensive HLA and disease associations analysis software.

Kanterakis S, Magira E, Rosenman KD, Rossman M, Talsania K, Monos DS. Kanterakis S, et al. Among authors: rossman m. Hum Immunol. 2008 Aug;69(8):522-5. doi: 10.1016/j.humimm.2008.05.011. Epub 2008 Jul 2. Hum Immunol. 2008. PMID: 18601964

10

Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity.

Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D. Rossman MD, et al. Am J Respir Crit Care Med. 2002 Mar 15;165(6):788-94. doi: 10.1164/ajrccm.165.6.2104002. Am J Respir Crit Care Med. 2002. PMID: 11897645

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page